《ESH2013歐洲高血壓指南》內容簡(jiǎn)介
今天由歐洲高血壓學(xué)會(huì )(ESH)及歐洲心臟病學(xué)會(huì )(ESC)發(fā)布的該聯(lián)合指南強調,高血壓治療面臨的主要問(wèn)題包括醫生及患者對生活方式的重視程度不夠、在啟動(dòng)及強化藥物治療的問(wèn)題上常猶豫不決以及醫療保健系統的結構性缺陷。新指南對高血壓治療的幾項推薦做了明顯修改,于今天在意大利米蘭舉行的歐洲高血壓學(xué)會(huì )年會(huì )上正式發(fā)布,并同時(shí)在線(xiàn)發(fā)表在《高血壓雜志》、《歐洲心臟雜志》及《血壓》上。
《ESH2013歐洲高血壓指南》內容預覽
2.2 Definition and classificationof hypertensionThe continuous relationship between BP and CV and renal eventsmakes the distinction between normotension and hypertension dif-ficult when based on cut-off BP values. This is even more sobecause, in the general population, SBP and DBP values have a uni-modal distribution.
In practice, however, cut-off BP values are uni-versally used, both to simplify the diagnostic approach and to facilitatethe decision about treatment. The recommended classification is un-changed from the 2003 and 2007 ESH/ESC guidelines (Table3 )。Hypertension is defined as values ≥ 140 mmHg SBP and/or≥ 90 mmHg DBP, based on the evidence from RCTs that in patientswith these BP values treatment-induced BP reductions are beneficial(see Sections 4.1 and 4.2)。 The same classification is used in young,middle-aged and elderly subjects, whereas different criteria, basedon percentiles, are adopted in children and teenagers for whomdata from interventional trials are not available. Details on BP classi-fication in boys and girls according to their age and height can befound in the ESH's report on the diagnosis, evaluation and treatmentof high BP in children and adolescents.
點(diǎn)擊下載***《ESH2013歐洲高血壓指南》
意見(jiàn)反饋 關(guān)于我們 隱私保護 版權聲明 友情鏈接 聯(lián)系我們
Copyright 2002-2025 Iiyi.Com All Rights Reserved